FR2213768A1 - - Google Patents

Info

Publication number
FR2213768A1
FR2213768A1 FR7400844A FR7400844A FR2213768A1 FR 2213768 A1 FR2213768 A1 FR 2213768A1 FR 7400844 A FR7400844 A FR 7400844A FR 7400844 A FR7400844 A FR 7400844A FR 2213768 A1 FR2213768 A1 FR 2213768A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7400844A
Other languages
French (fr)
Other versions
FR2213768B1 (en:Method
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of FR2213768A1 publication Critical patent/FR2213768A1/fr
Application granted granted Critical
Publication of FR2213768B1 publication Critical patent/FR2213768B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FR7400844A 1973-01-15 1974-01-10 Expired FR2213768B1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI496A HU166289B (en:Method) 1973-01-15 1973-01-15

Publications (2)

Publication Number Publication Date
FR2213768A1 true FR2213768A1 (en:Method) 1974-08-09
FR2213768B1 FR2213768B1 (en:Method) 1977-07-01

Family

ID=11000913

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7400844A Expired FR2213768B1 (en:Method) 1973-01-15 1974-01-10

Country Status (13)

Country Link
JP (1) JPS505521A (en:Method)
AT (1) AT332552B (en:Method)
AU (1) AU6354673A (en:Method)
BE (1) BE809693A (en:Method)
CS (1) CS172273B2 (en:Method)
DD (1) DD108460A5 (en:Method)
DE (1) DE2362337A1 (en:Method)
DK (1) DK134742B (en:Method)
FR (1) FR2213768B1 (en:Method)
GB (1) GB1440275A (en:Method)
HU (1) HU166289B (en:Method)
IL (1) IL43814A0 (en:Method)
NL (1) NL7317458A (en:Method)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54125630A (en) * 1978-02-22 1979-09-29 Nippon Zoki Pharmaceutical Co Novel propanone derivative*its manufacture and medical composition containing it as active component

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Also Published As

Publication number Publication date
AT332552B (de) 1976-10-11
DK134742B (da) 1977-01-10
CS172273B2 (en) 1976-12-29
ATA22374A (de) 1976-01-15
IL43814A0 (en) 1974-03-14
FR2213768B1 (en:Method) 1977-07-01
HU166289B (en:Method) 1975-02-28
NL7317458A (en:Method) 1974-07-17
BE809693A (fr) 1974-05-02
AU6354673A (en) 1975-06-12
DD108460A5 (en:Method) 1974-09-20
JPS505521A (en:Method) 1975-01-21
GB1440275A (en) 1976-06-23
DE2362337A1 (de) 1974-07-18

Similar Documents

Publication Publication Date Title
AR201758A1 (en:Method)
AR201235Q (en:Method)
AR201231Q (en:Method)
AU474593B2 (en:Method)
AU471343B2 (en:Method)
AU465453B2 (en:Method)
AU450229B2 (en:Method)
AU476714B2 (en:Method)
AR201229Q (en:Method)
AU476696B2 (en:Method)
AU472848B2 (en:Method)
AR199451A1 (en:Method)
AU466283B2 (en:Method)
FR2213768B1 (en:Method)
AU477823B2 (en:Method)
AR197627A1 (en:Method)
AR200256A1 (en:Method)
AR193950A1 (en:Method)
AR195948A1 (en:Method)
AR200885A1 (en:Method)
AR196382A1 (en:Method)
AU461342B2 (en:Method)
AR195311A1 (en:Method)
AR210729A1 (en:Method)
AU477824B2 (en:Method)

Legal Events

Date Code Title Description
ST Notification of lapse